Is self-monitoring an effective option for people receiving long-term vitamin K antagonist therapy? A systematic review and economic evaluation

BMJ Open

Volumn 5, Issue 6, 2015, Pages

  Sharma, Pawana ^a   Scotland, Graham ^a,b   Cruickshank, Moira ^a   Tassie, Emma ^b   Fraser, Cynthia ^a   Burton, Christopher ^b   Croal, Bernard ^b   Ramsay, Craig R ^a   Brazzelli, Miriam ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; ANTICOAGULANT AGENT; VITAMIN K GROUP;

ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING; CLINICAL EFFECTIVENESS; COAGULOMETER; COMPARATIVE EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; LONG TERM CARE; MORTALITY; POINT OF CARE TESTING; QUALITY OF LIFE; SELF CARE; SELF MONITORING; SOCIAL CARE; SYSTEMATIC REVIEW; THROMBOEMBOLISM; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; COST BENEFIT ANALYSIS; ECONOMICS;

ANTICOAGULANTS; COST-BENEFIT ANALYSIS; HEMORRHAGE; HUMANS; SELF CARE; THROMBOEMBOLISM; VITAMIN K;

EID: 84937199128     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-007758     Document Type: Article

References (71)

1. DeWilde S, Carey IM, Emmas C, et al Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart 2006; 92:1064-70.
2. Camm AJ, Kirchhof P, Lip G.Y., et al., European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31:2369-429.
3. Cowan C, Healicon R, Robson I., et al. The use of anticoagulants in the management of atrial fibrillation among general practices in England. Heart 2013; 99:1166-72.
4. Heart valve disease [website on the Internet]. London: British Heart Foundation, 2013. http://www.bhf.org.uk/heart-health/conditions/heart-valve-disease.aspx (accessed Apr 2015).
5. Aortic stenosis [website on the Internet]. Leeds: Patient UK, 2013. http://www.patient.co.uk/health/aortic-stenosis (accessed Apr 2015).
6. UK Heart Valve Registry [archived webpage on the Internet]. London: NHS Health and Social Care Information Centre, 2010. http://docdat.ic.nhs.uk/DatabaseList.aspx (accessed Apr 2015).
7. Cayley J. Self-monitoring and self-management of anticoagulation therapy. Am Fam Physician 2011; 84:266-8.
8. Anticoagulation therapy service commissioning guide [document on the Internet]. London: National Insititute for Health and Care Excellence, 2010. URL:http://www.nice.org.uk/usingguidance/commissioningguides/anticoagulationtherapyservice/anticoagulationtherapyservice.jsp (accessed Apr 2015).
9. Atrial fibrillation [website on the Internet]. London: British Heart Foundation, 2013. http://www.bhf.org.uk/heart-health/conditions/atrial-fibrillation.aspx (accessed Apr 2015).
10. SIGN 129 Antithrombotics: indications and management [document on the Internet]. Edinburgh: Health Improvement Scotland, 2013. http://www.sign.ac.uk/pdf/SIGN129.pdf (accessed April 2015).
11. Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation. NICE Guidance TA249 [document on the Internet]. London: National Insititute for Health and Care Excellence, 2012. http://guidance.nice.org.uk/TA249 (accessed Apr 2015).
12. Fuster V, Ryden LE, Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006; 8:651-745.
13. You JJ, Singer DE, Howard P.A., et al. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl):e531S-75S.
14. Connock M, Stevens C, Fry-Smith A, et al. Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling. Health Technol Assess 2007; 11:iii-iv, ix-66.
15. Ansell J, Jacobson A, Levy J., et al. International Self-Monitoring Association for Oral Anticoagulation. Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation. Int J Cardiol 2005; 99:37-45.
16. Point-of-Care Testing: A Review of Systematic Reviews on Testing Accuracy and Cost-Effectiveness [document on the Internet]. Ottawa: Canadian Agency for Drugs and Technologies in Health, 2012. http://www.cadth.ca/media/pdf/htis/april-2012/RC0345%20Point%20of%20Care%20Testing%20Final.pdf (accessed Apr 2015).
17. Christensen TD, Larsen TB Precision and accuracy of point-of-care testing coagulometers used for self-testing and self-management of oral anticoagulation therapy. J Thromb Haemost 2012; 10:251-60.
18. Tamayo AE, Vergara-Mitxeltorena I, Uranga Saez del BE, et al. Oral anticoagulation and self-management: Analysis of the factors that determine the feasibility of using self-testing and self-management in primary care. BMC Cardiovasc Disorder 2013; 13:59.
19. Jones S, Monagle P, Manias E., et al. Quality of life assessment in children commencing home INR self-testing. Thromb Res 2013; 132:37-43.
20. Garcia-Alamino J.M., Ward AM, Alonso-Coello P, et al. Self-monitoring and self-management of oral anticoagulation. Cochrane Database Syst Rev 2010; (4):CD003839. doi:10.1002/14651858.CD003839.pub2.
21. Systematic reviews: CRD's guidance for undertaking systematic reviews in health care [document on the Internet]. University of York: Centre for Reviews and Dissemination, 2009. http://www.york.ac.uk/inst/crd/SysRev/!SSL!/WebHelp/SysRev3.htm (accessed April 2015).
22. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [document on the Internet]. The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org/ (accessed April 2015).
23. National Institute for Health and Care Excellence. Guide to the methods of technology appraisal [document on the Internet]. London: National Institute for Health and Care Excellence, 2013. http://publications.nice.org.uk/guide-to-the-methods-of-technology-appraisal-2013-pmg9 (accessed Apr 2015).
24. Moher D, Liberati A, Tetzlaff J., et al. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009; 62:1006-12.
25. Sonnenberg FA, Beck JR Markov models in medical decision making: a practical guide. Med Decis Making 1993; 13:322-38.
26. Beck JR, Pauker SG The Markov process in medical prognosis. Med Decis Making 1983; 3:419-58.
27. Point-of-Care International Normalized Ratio (INR) Monitoring Devices for Patients on Long-term Oral Anticoagulation Therapy. Ontario Health Asssessment Series 9 (12) [document on the Internet]. Ontario: Medical Advisory Secretariat Ministry of Health and Long-Term Care, 2009. http://www.health.gov.on.ca/english/providers/program/mas/tech/reviews/pdf/rev-poc-20090928.pdf (accessed Apr 2015).
28. Brown A, Wells P, Jaffey J., et al. Point-of-Care Monitoring Devices for Long-Term Oral Anticoagulation Therapy: Clinical and Cost Effectiveness. Technology Report no 72 [document on the Internet]. Ottawa: Canadian Agency for Drugs and Technologies in Health, 2007. http://www.cadth.ca/media/pdf/H0299-anticoagulation-therapy-tr-e.pdf (accessed Apr 2015).
29. Gailly J, Gerkens S, van den Bruel A, et al. Use of point-of-care devices in patients with oral anticoagulation: a Health Technology Assessment. KCE Report 117C [document on the Internet]. Brussels: Belgian Health Care Knowledge Centre, 2009. https://kce.fgov.be/publication/report/use-of-point-of-care-devices-in-patients-with-oral-anticoagulation-a-health-techn (accessed Apr 2015).
30. Lafata JE, Martin SA, Kaatz S, et al The cost-effectiveness of different management strategies for patients on chronic warfarin therapy. J Gen Intern Med 2000; 15:31-7.
31. Muller E, Bergemann R, GELIA Study Group. Economic analysis of bleeding and thromboembolic sequelae after heart valve replacement (GELIA 7). Eur Heart J Suppl 2001; 3(Suppl Q):65-9.
32. Regier DA, Sunderji R, Lynd L.D., et al. Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy. CMAJ 2006; 174:1847-52.
33. Sola-Morales O. Portable coagulometers: revision of the scientific evidence and economic assessment of their use in self-control of oral anticoagulant treatment. Barcelona: Catalan Agency for Health Technology Assessment and Research (CAHTA), 2003.
34. Taborski U, Wittstamm FJ, Bernardo A. Cost-effectiveness of self-managed anticoagulant therapy in Germany. Semin Thromb Hemost 1999; 25:103-7.
35. Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation NICE Guidance TA256 [document on the Internet]. London: National Insititute for Health and Care Excellence, 2012. http://guidance.nice.org.uk/TA256 (accessed Apr 2015).
36. NICE Diagnostic Assessment Programme manual [document on the Internet]. London: National Institute for Health and Care Excellence, 2011. http://www.nice.org.uk/media/A0B/97/DAPManualFINAL.pdf (accessed April 2015).
37. NHS reference costs 2011-12 [website on the Internet]. UK Department of Health, 2012. https://www.gov.uk/government/publications/nhs-reference-costs-financial-year-2011-to-2012 (accessed Apr 2015).
38. Curtis L. Unit Costs of Health and Social Care 2013 [document on the Internet]. Canterbury: Personal Social Services Research Unit, 2012. http://www.pssru.ac.uk/project-pages/unit-costs/2012/ (accessed Apr 2015).
39. Christensen TD, Maegaard M, Sorensen H.T., et al. Self-management versus conventional management of oral anticoagulant therapy: a randomized, controlled trial. Eur J Intern Med 2006; 17:260-6.
40. Cromheecke ME, Levi M, Colly L.P., et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet 2000; 356:97-102.
41. Eitz T, Schenk S, Fritzsche D, et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Ann Thorac Surg 2008; 85: 949-54.
42. Fitzmaurice DA, Murray ET, Gee K.M., et al. A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. J Clin Pathol 2002; 55:845-9.
43. Fitzmaurice DA, Murray ET, McCahon D, et al Self management of oral anticoagulation: randomised trial. BMJ 2005; 331:1057.
44. Hemkens LG, Hilden KM, Hartschen S, et al A randomized trial comparing INR monitoring devices in patients with anticoagulation self-management: evaluation of a novel error-grid approach. J Thromb Thrombol 2008; 26:22-30.
45. Horstkotte D, Piper C, Wiemer M., et al. Improvement of prognosis by home prothrombin estimation In patients with life-long anticoagulant therapy. Eur Heart J 1996; 17:230.
46. Kortke H, Minami K, Breymann T., et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Z Kardiol 2001; 90(Suppl 6):VI/118-24.
47. Menéndez J.B., Souto JC, Oliver A, et al Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Ann Intern Med 2005; 142:1-10.
48. Rasmussen RS, Corell P, Madsen P., et al. Effects of computer-assisted oral anticoagulant therapy. Thromb J 2012; 10:17.
49. Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA 1999; 281:145-50.
50. Sidhu P, O'Kane HO. Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Ann Thorac Surg 2001; 72:1523-7.
51. Siebenhofer A, Rakovac I, Kleespies C., et al., SPOG 6. Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thromb Haemost 2008; 100:1089-98.
52. Soliman H, van E, van A., et al. Self-management program improves anticoagulation control and quality of life: a prospective randomized study. Eur J Cardiothorac Surg 2009; 35:265-9.
53. Sunderji R, Gin K, Shalansky K., et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Can J Cardiol 2004; 20:1117-23.
54. Verret L, Couturier J, Rozon A., et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy 2012; 32:871-9.
55. Völler H., Glatz J, Taborski U., et al. Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Zeitschrift für Kardiologie 2005; 94:182-6.
56. Azarnoush K, Camilleri L, Aublet-Cuvelier B, et al. Results of the first randomized French study evaluating self-testing of the International Normalized Ratio. J Heart Valve Dis 2011; 20:518-25.
57. Christensen TD. Self-management of oral anticoagulation therapy - methodological and clinical aspects. Dan Med Bull 2011; 58:B4284.
58. Gardiner C, Williams K, Mackie I.J., et al. Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. Br J Haematol 2005; 128:242-7.
59. Khan TI, Kamali F, Kesteven P., et al. The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. Br J Haematol 2004; 126:557-64.
60. Matchar DB, Jacobson A, Dolor R., et al. Effect of home testing of international normalized ratio on clinical events. N Engl J Med 2010; 363:1608-20.
61. Ryan F, Byrne S, O'Shea S. Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system. J Thromb Haemost 2009; 7:1284-90.
62. Gadisseur AP, Breukink-Engbers WG, Meer F.J., et al. Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Arch Intern Med 2003; 163:2639-46.
63. Bauman ME, Black K, Bauman M.L., et al. EMPoWarMENT: Edmonton pediatric warfarin self-management pilot study in children with primarily cardiac disease. Thromb Res 2010; 126: e110-15.
64. Gardiner C, Williams K, Longair I., et al. A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing. Br J Haematol 2006; 132:598-603.
65. Siebenhofer A, Rakovac I, Kleespies C., et al. Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thromb Haemost 2007; 97:408-16.
66. Bloomfield HE, Krause A, Greer N., et al. Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes. Ann Intern Med 2011; 154:472-82.
67. Heneghan C, Alonso-Coello P, Garcia-Alamino JM, et al. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006; 367:404-11.
68. Heneghan C, Ward A, Perera R., et al. Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet 2012; 379:322-34.
69. Wells PS, Brown A, Jaffey J., et al. Safety and effectiveness of point-of-care monitoringdevices in patients on oral anticoagulant therapy: a meta-analysis. Open Medicine 2007; 1:E131-46.
70. Bayer PLC. Single Technology Appraisal (STA) of Rivaroxaban (Xarelto®) [document on the Internet]. London: National Institute for Health and Care Excellence, 2011. http://guidance.nice.org.uk/TAG/274/Consultation/EvaluationReport/ManufacturerSubmissions/Bayer/pdf/English (accessed Apr 2015).
71. Jowett S, Bryan S, Murray E., et al. Patient self-management of anticoagulation therapy: a trial-based cost-effectiveness analysis. Br J Haematol 2006; 134:632-9.